hsa-miR-221

ncRNA information

ncRNA name

hsa-miR-221

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Multiple Myeloma

Cancer site

Multiple Myeloma

Treatment information

Treatment type

Chemotherapy

Drug

Dexamethasone

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Knockdown of miR-221 and miR-222 in MM1R cells partially restores PUMA expression and Dex sensitivity in vitro.

Tissue resource

multiple myeloma cell lines MM1S

multiple myeloma cell lines MM1R

multiple myeloma cell lines MM1S

multiple myeloma cell lines MM1R

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

American Type Culture Collection

Country

USA

Continent

Amercia